Item Details

Parkinson's [electronic resource]: Great Drug Experiment

TVF International (Firm)
Format
Video; Computer Resource; Online Video; Online
Summary
Once diagnosed with Parkinson's disease, most patients can expect a stable and active lifestyle for up to a decade-but new drugs could lengthen that period. This program follows five volunteers in the clinical trial of MitoQ, a medicine designed to slow the ailment's progress. Viewers are taken through the yearlong, double-blind placebo-controlled study, in which each volunteer performs a daily regimen of physical and mental exercise while his or her symptom progression is closely monitored. Interviews feature Dr. Barry Snow, the neurologist in charge of the trial, and Ken Taylor, CEO of Antipodean Pharmaceuticals, which makes and markets MitoQ.
Release Date
2009
Run Time
45 min.
Language
English
Rating
10 & up
Notes
  • Encoded with permission for digital streaming by Films Media Group on Nov. 06, 2009.
  • Films on Demand is distributed by Films Media Group for Films for the Humanities & Sciences, Cambridge Educational, Meridian Education, and Shopware.
Variant Title
Great drug experiment
Contents
  • Incidence of Parkinson's Disease (0:59)
  • What Is Parkinson's? (1:09)
  • Brain Chemicals and Signals (1:23)
  • Parkinson's Disease and Movement (1:17)
  • New Drug for Parkinson's (1:11)
  • Volunteers Test Drugs (1:01)
  • Challenge of Parkinson's (1:01)
  • New Drug: New Hope (1:05)
  • Double-Blind Drug Study (1:00)
  • Drug Test Volunteer (1:02)
  • Placebo Effect (0:58)
  • Drug Test Measurements (1:11)
  • Scientific Breakthrough (1:24)
  • Blood-Brain Barrier (1:01)
  • Money for Science (1:12)
  • Drug Test Dropouts (1:10)
  • Test Invalidation (1:18)
  • Lifestyle Changes (1:55)
  • Brain Cell Death (1:48)
  • Problems with Mitochondria (1:08)
  • Antioxidants (0:58)
  • Value of Co-Enzyme Q10 (1:05)
  • Increase of Symptoms (0:59)
  • Drug Trial Drop Out (1:02)
  • Valid Test Data (1:01)
  • Comparison of Conditions (1:49)
  • Medications to Treat Symptoms (1:41)
  • Return of Symptoms (1:13)
  • Participant Speculation (1:59)
  • Test Results: Drug Failure (2:00)
  • Psychosomatic Response (1:14)
  • Disappointment in Test Results (1:22)
  • Need for Drug Testers (0:36)
  • More to Learn About Parkinson's (2:00)
Published
New York, N.Y. : Films Media Group, [2009], c2008.
Publisher no.
40663 Films Media Group
Access Restriction
Access requires authentication through Films on Demand.
Description
1 streaming video file (45 min.) : sd., col., digital file.
Mode of access: Internet.
System requirements: FOD playback platform.
Technical Details
  • Access in Virgo Classic

  • LEADER 03672ngm a2200493Ia 4500
    001 u6088806
    003 SIRSI
    005 20120926151047.0
    006 m|||| o||c| ||||||
    007 cr|cnannnuuuuu
    007 vz|czazuu
    008 101228s2009 nyu045| ||||| o|||vleng d
    028
    4
    0
    a| 40663 b| Films Media Group
    035
      
      
    a| 100040663
    035
      
      
    a| (OCoLC)709677237
    040
      
      
    a| AzPhAEM
    245
    0
    0
    a| Parkinson's h| [electronic resource] : b| great drug experiment / c| TVF International (Firm)
    246
    3
      
    a| Great drug experiment
    260
    3
      
    a| New York, N.Y. : b| Films Media Group, c| [2009], c2008.
    300
      
      
    a| 1 streaming video file (45 min.) : b| sd., col., digital file.
    500
      
      
    a| Encoded with permission for digital streaming by Films Media Group on Nov. 06, 2009.
    500
      
      
    a| Films on Demand is distributed by Films Media Group for Films for the Humanities & Sciences, Cambridge Educational, Meridian Education, and Shopware.
    505
    0
      
    a| Incidence of Parkinson's Disease (0:59) -- What Is Parkinson's? (1:09) -- Brain Chemicals and Signals (1:23) -- Parkinson's Disease and Movement (1:17) -- New Drug for Parkinson's (1:11) -- Volunteers Test Drugs (1:01) -- Challenge of Parkinson's (1:01) -- New Drug: New Hope (1:05) -- Double-Blind Drug Study (1:00) -- Drug Test Volunteer (1:02) -- Placebo Effect (0:58) -- Drug Test Measurements (1:11) -- Scientific Breakthrough (1:24) -- Blood-Brain Barrier (1:01) -- Money for Science (1:12) -- Drug Test Dropouts (1:10) -- Test Invalidation (1:18) -- Lifestyle Changes (1:55) -- Brain Cell Death (1:48) -- Problems with Mitochondria (1:08) -- Antioxidants (0:58) -- Value of Co-Enzyme Q10 (1:05) -- Increase of Symptoms (0:59) -- Drug Trial Drop Out (1:02) -- Valid Test Data (1:01) -- Comparison of Conditions (1:49) -- Medications to Treat Symptoms (1:41) -- Return of Symptoms (1:13) -- Participant Speculation (1:59) -- Test Results: Drug Failure (2:00) -- Psychosomatic Response (1:14) -- Disappointment in Test Results (1:22) -- Need for Drug Testers (0:36) -- More to Learn About Parkinson's (2:00)
    506
      
      
    a| Access requires authentication through Films on Demand.
    520
      
      
    a| Once diagnosed with Parkinson's disease, most patients can expect a stable and active lifestyle for up to a decade-but new drugs could lengthen that period. This program follows five volunteers in the clinical trial of MitoQ, a medicine designed to slow the ailment's progress. Viewers are taken through the yearlong, double-blind placebo-controlled study, in which each volunteer performs a daily regimen of physical and mental exercise while his or her symptom progression is closely monitored. Interviews feature Dr. Barry Snow, the neurologist in charge of the trial, and Ken Taylor, CEO of Antipodean Pharmaceuticals, which makes and markets MitoQ.
    521
    2
      
    a| 10 & up.
    538
      
      
    a| Mode of access: Internet.
    538
      
      
    a| System requirements: FOD playback platform.
    650
      
    0
    a| Aging.
    650
      
    0
    a| Diseases x| Treatment.
    650
      
    0
    a| Medicine x| Research.
    650
      
    0
    a| Nervous system x| Diseases.
    650
      
    0
    a| Pharmacology.
    655
      
    0
    a| Educational films.
    655
      
    0
    a| Internet videos.
    655
      
    7
    a| Videorecording. 2| local
    710
    2
      
    a| Films for the Humanities & Sciences (Firm)
    710
    2
      
    a| Films Media Group.
    710
    2
      
    a| TVF International (Firm)
    776
    0
    8
    i| Originally produced: d| TVF International (Firm), 2009 z| 9781616162559
    856
    4
    0
    z| Part of the Films on Demand collection. u| http://proxy01.its.virginia.edu/login?url=http://digital.films.com/PortalPlaylists.aspx?aid=29178&xtid=40663
    596
      
      
    a| 1
    999
      
      
    a| XX(6088806.1) w| WEB i| 6088806-1001 l| INTERNET m| UVA-LIB t| INTERNET

Availability

Google Preview

NOTE: When running on Google Chrome, the supplied viewer is not capable of entering fullscreen mode -- please visit the link in the Availability section above for that capability.